Target Group Inc. cash flow statement CBDY

Annual Quarterly

In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, Target Group Inc. used $222,908 of cash from operations, down 146.0% from the same quarter a year earlier.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Operating
Depreciation and amortization	1 -1.1%	0 +0.9%	0 +5.1%	0 -16.5%	0 +10.2%	0 -48.4%	0	0 +105.1%	0 -13.1%
Operating cash flow	-1 -433.8%	-0 -146.0%	-0 +83.6%	-0 -134.1%	-1 -53.7%	0 -72.4%	-1	1 +154.2%	-0 +75.7%
Investing
Investing cash flow	-0 +93.9%	-0 -141.0%	-0 -243.2%	0 +126.0%	0 +117.2%	0 +14.8%	0	-0 -177.3%	-0 -118.5%
Financing
Financing cash flow	0 +125.0%	0 +106.2%	0 +143.2%	-0 -113.8%	-0 -927.6%	-0 +32.3%	-1	0 +342.3%	0 -10.1%
Ratios
Cash conversion	—	—	—	—	—	—	—	3.41x	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: CBDY (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Hamilton
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1586554
Former names: Chess Supersite Corp (until Jul 3, 2018); River Run Acquisition Corp (until May 13, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.